<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>

武漢先路醫藥科技股份有限公司歡迎您的光臨Welcome !
?
?
當前位置:首頁 > 新聞中心 > 行業動態

關于發布《臨床價值明確,無法推薦參比制劑的化學藥品目錄(第一批)》的公示

來源:CFDE  發布時間:2020-08-27  瀏覽量:1899

關于發布《臨床價值明確,無法推薦參比制劑的化學藥品目錄(第一批)》的公示

發布日期:20200827

       根據國家局2020年5月14日發布的《關于開展化學藥品注射劑仿制藥質量和療效一致性評價工作的公告》(2020年第62號),我中心組織遴選了《臨床價值明確,無法推薦參比制劑的化學藥品目錄(第一批)》(見附件),現在中心網站予以公示。歡迎各界提出寶貴意見和建議,并請及時反饋給我們。
       公示期限:2020年8月27日~2020年9月9日
       聯系郵箱:cdecbzj@cde.org.cn

                                                                                                                                 國家藥品監督管理局藥品審評中心
                                                                                                                                         2020年8月27日

       

       附件1:臨床價值明確,無法推薦參比制劑的化學藥品目錄(第一批)(征求意見稿) 

        附件2:征求意見反饋表

?
網站首頁| 關于先路| 產品中心| 研發體系| 合作伙伴| 新聞中心| 職業機會| 聯系我們
国产一级黄片

<output id="zjvxt"><video id="zjvxt"></video></output>

<video id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></video><font id="zjvxt"></font>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>

<p id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></p>
<noframes id="zjvxt">
<output id="zjvxt"></output><p id="zjvxt"></p>
<output id="zjvxt"></output>

<p id="zjvxt"></p>
<p id="zjvxt"></p>

<p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"></output></video>
<output id="zjvxt"><delect id="zjvxt"></delect></output>
<video id="zjvxt"><output id="zjvxt"></output></video>

<video id="zjvxt"></video>

<p id="zjvxt"><output id="zjvxt"></output></p>

<video id="zjvxt"><output id="zjvxt"></output></video><video id="zjvxt"></video>
<output id="zjvxt"><output id="zjvxt"></output></output>
<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>

<p id="zjvxt"><delect id="zjvxt"><font id="zjvxt"></font></delect></p>
<video id="zjvxt"></video><p id="zjvxt"></p>
<video id="zjvxt"><output id="zjvxt"><delect id="zjvxt"></delect></output></video>

<video id="zjvxt"><output id="zjvxt"></output></video>
<p id="zjvxt"><delect id="zjvxt"></delect></p>

<output id="zjvxt"><output id="zjvxt"></output></output><output id="zjvxt"></output>
<p id="zjvxt"><output id="zjvxt"></output></p>
<p id="zjvxt"></p>
<p id="zjvxt"></p>